跳至主要内容
临床试验/NCT01062841
NCT01062841已完成不适用

Targeted Infection Control Program (TIP) to Reduce Resistant Pathogens and Infections

University of Michigan1 个研究点 分布在 1 个国家目标入组 418 人开始时间: 2010年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
418
试验地点
1
主要终点
Total Number of MRSA (Methicillin Resistant Staphylococcus Aureus) Isolated

研究概览

简要总结

This is an interventional study aimed at reducing multi-drug resistance and infections in nursing home (NH) residents. Each year, a staggering 1.5-2.0 million infections occur in NHs. Many of these infections are caused by multiple drug resistant organisms (MDROs) including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug resistant Gram-negative bacilli (R-GNB). Antimicrobial resistance among common bacteria are adversely affecting the clinical course and exponentially increasing healthcare costs. Recognizing a need for action, legislators, policy makers, and consumer groups are advocating for pathogen-based universal preemptive screening for these MDROs, particularly MRSA in hospitals and NHs. However, implementing this sweeping mandate is controversial, costly, reactive, and not based on empirical evidence. It can result in a 10-20-fold increase in the number of NH residents placed in isolation precautions with the potential for reduced attention by healthcare workers, isolation and functional decline. The investigators proposal evaluates a novel focused approach between 'do nothing' and 'search all and destroy' strategies by targeting a subgroup of NH residents with indwelling devices who are at a high risk of acquiring MDROs and infections.

The investigators hypothesize that the investigators targeted infection control program (TIP) will reduce MDRO colonization and infections in NH residents with indwelling devices. This cluster randomized trial will involve 12 NHs; 6 will be randomized to the TIP arm and 6 to the routine care arm. The investigators TIP intervention will include four components.

详细描述

Component 1: Institute enhanced barrier precautions for all NH residents with indwelling devices; active screening for MDROs (monthly) using cultures collected from multiple body sites to identify asymptomatic MDRO carriage in these residents; and dissemination of results to clinical staff and administration.

Component 2: Structured, active surveillance for infections using standardized definitions in residents with indwelling devices and dissemination of results to clinical staff and administration.

Component 3: A hand hygiene promotion program.

Component 4: A structured educational program pertaining to indwelling device care for healthcare workers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any short- or long-stay resident with an indwelling urinary catheter or feeding tube for more than 72 hours
  • Ability to get informed consent from either the resident or his/her durable power of attorney

排除标准

  • Having an indwelling device for less than 72 hours
  • Refusal of consent to get surveillance cultures and data collection by the resident or his/her durable power of attorney
  • Residents who are receiving end-of-life care

研究组 & 干预措施

Intervention: Targeted Infection Control

Active Comparator

Nursing homes allocated to the Intervention Arm will implement a series of new infection control programs.

干预措施: Targeted Infection Control (Behavioral)

Control

No Intervention

Nursing homes allocated to the control group will continue with their standard infection control procedures. No changes will be made to their practices.

结局指标

主要结局

Total Number of MRSA (Methicillin Resistant Staphylococcus Aureus) Isolated

时间窗: From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study

Total Number of MDRO (Multidrug Resistant Organisms) Isolated

时间窗: From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study

Total Number of MDROs isolated across all MDROs and all anatomic sites for all enrolled residents with indwelling devices over the duration of the study period

Total Number of VRE (Vancomycin Resistant Enterococci) Isolated

时间窗: From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study

Total Number of Ciprofloxacin-resistant GNB (Gram-negative Bacilli) Isolated

时间窗: From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study

Total Number of Ceftazidime-resistant GNB (Gram-negative Bacilli) Isolated

时间窗: From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study

次要结局

  • Number of First Incident Urinary Catheter-associated Urinary Tract Infections(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Total Number of Residents With New MRSA (Methicillin Resistant Staphylococcus Aureus) Acquisition(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Total Number of Residents With New Resistant GNB (Ceftazidime or Ciprofloxacin Gram-negative Bacilli) Acquisition(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Number of All (First and Recurrent) Incident Urinary Catheter-associated Urinary Tract Infections(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Number of Incident Feeding Tube-associated Skin and Soft Tissue Infections(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Number of Incident Feeding-tube Associated Pneumonias(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)
  • Total Number of Residents With New VRE (Vancomycin Resistant Enterococci) Acquisition(From enrollment up to 1 year, or until study withdrawal (indwelling device removed, discharged from facility, at resident request, death), or end of study)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lona Mody

Associate Professor, Internal Medicine, Division of Geriatric and Palliative Medicine

University of Michigan

研究点 (1)

Loading locations...

相似试验